Curetis AG
2 known investors
Find your way into Curetis AG
Sign up to see every warm intro you have to Curetis AG
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Curetis AG team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Curetis develops molecular diagnostic systems for detecting pathogens and antimicrobial resistance markers in severe infections. Its testing solution provides physicians with rapid results to guide treatment decisions for infectious diseases.
Investors · 2
BioMedPartnerslisted by BioMedPartnersBasel · $648K – $6.5M
How we know: BioMedPartners's portfolio page · Not right? Tell us
ForbionreportedNaarden
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Curetis AG do?
- Curetis develops molecular diagnostic systems for detecting pathogens and antimicrobial resistance markers in severe infections. Its testing solution provides physicians with rapid results to guide treatment decisions for infectious diseases.
- Who are Curetis AG's investors?
- Curetis AG's investors include BioMedPartners, Forbion.
